Cargando…
How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187608/ https://www.ncbi.nlm.nih.gov/pubmed/37200543 http://dx.doi.org/10.21037/aob-21-87 |
| _version_ | 1785042767960866816 |
|---|---|
| author | Zheng, Lucy Zheng, X. Long |
| author_facet | Zheng, Lucy Zheng, X. Long |
| author_sort | Zheng, Lucy |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10187608 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101876082023-06-30 How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura? Zheng, Lucy Zheng, X. Long Ann Blood Article 2023-06-30 2022-04-01 /pmc/articles/PMC10187608/ /pubmed/37200543 http://dx.doi.org/10.21037/aob-21-87 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the noncommercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
| spellingShingle | Article Zheng, Lucy Zheng, X. Long How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura? |
| title | How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura? |
| title_full | How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura? |
| title_fullStr | How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura? |
| title_full_unstemmed | How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura? |
| title_short | How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura? |
| title_sort | how should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura? |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187608/ https://www.ncbi.nlm.nih.gov/pubmed/37200543 http://dx.doi.org/10.21037/aob-21-87 |
| work_keys_str_mv | AT zhenglucy howshouldcaplacizumabbeusedfortreatmentofimmunethromboticthrombocytopenicpurpura AT zhengxlong howshouldcaplacizumabbeusedfortreatmentofimmunethromboticthrombocytopenicpurpura |